MASLD
The fibrosis tools, images and patient information for metabolic dysfunction-associated steatotic liver disease, in one place.
Everything here lives somewhere else on this site. Nothing on this page is advice on how to treat anyone; it is a way of finding the tools in one step.
Scores and calculators
FIB-4 index
Risk of advanced liver fibrosis from age, AST, ALT and platelet count.
MASLD fibrosis panel
FIB-4, NAFLD fibrosis score, APRI, BARD and the AST to ALT ratio together, with how well they agree and the next step.
NAFLD fibrosis score
Risk of advanced fibrosis in MASLD from age, BMI, diabetes, AST, ALT, platelets and albumin.
Fatty Liver Index
Likelihood of hepatic steatosis from triglycerides, BMI, GGT and waist circumference.
APRI
AST to platelet ratio index for significant fibrosis and cirrhosis.
BARD score
Simple score to exclude advanced fibrosis in MASLD from BMI, AST/ALT ratio and diabetes.
FAST score
FibroScan-AST score for at-risk steatohepatitis (MASH with NAS 4 or more and F2 or more).
MEFIB index
MR elastography combined with FIB-4 to rule significant fibrosis in or out in MASLD.
SAFE score
Steatosis-associated fibrosis estimator for significant fibrosis in MASLD, for primary care.
Fibrotic NASH Index (FNI)
Likelihood of fibrotic steatohepatitis (MASH with F2 or more) from AST, HbA1c and HDL.
NAFLD Activity Score (NAS)
Histological activity score for steatotic liver disease: steatosis, lobular inflammation and ballooning.
Images to show a patient
Patient information
- Fatty Liver Disease (GESA)opens in a new tab
- All GESA handouts